Evidence map›Paper›PMID 41091248›Full record

ReviewFish physiology and biochemistry2025

All that glitters is not gold: towards the standardization of experimental trials assessing functional feeds with immunomodulatory properties.

Enric Gisbert, Dolors Furones, Silvia Torrecillas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Fish physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Enric GisbertIRTA, Aquaculture Program, Crta. Poble Nou Km 5.5, 43450, La Ràpita, Spain. enric.gisbert@irta.cat.
Dolors FuronesIRTA, Aquaculture Program, Crta. Poble Nou Km 5.5, 43450, La Ràpita, Spain.
Silvia TorrecillasIRTA, Aquaculture Program, Crta. Poble Nou Km 5.5, 43450, La Ràpita, Spain.

Funding

Agencia Estatal de Investigación PID2023-147976OR-C21
6 · The paper itself

Abstract

Functional feeds designed to enhance the host's immune response and improve disease resistance are among the most popular strategies to mitigate the impact of infectious diseases and abiotic stressors in aquaculture. While reviewing the current scientific literature on this issue, we have detected that there is a need to standardize the evaluation criteria for feed additives with immunostimulant properties in terms of the duration of the trial and selection of key end-points related to the expected effect of the dietary intervention. The evaluation of the disease protective role of a feed additive should not be based only on end-points from cellular and immune biomarkers, but it should also be complemented with end-points based on survival data of specimens exposed to an in vivo infective challenge. We also recommend giving special consideration to the basal diet used in these studies since the inclusion of certain ingredients may have confounding results with those expected from the additive or functional ingredient of interest. Regardless of the in vivo challenge model selected (balneation, cohabitation, intraperitoneal injection, or oral/anal intubation), abiotic factors such as temperature, water flow, light, and water quality strongly influence the development of disease and must be also taken into consideration when designing experimental challenge models. Thus, it is of paramount importance to standardize the studies testing the efficacy of functional diets designed to protect the host from infectious agents and to assist in harmonizing the interpretation of their results.

Indexed as

Animal FeedAquacultureFishesAnimalsDietChallengeDisease resistanceFunctional feedsIn vivo trials

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.